FDA offers new hope for families facing rare disease
FDA offers renewed hope for families facing rare disease with the launch of the Accelerating Rare disease Cures (ARC) Program
rare disease
FDA offers renewed hope for families facing rare disease with the launch of the Accelerating Rare disease Cures (ARC) Program